title: Hakai reduces cell-substratum adhesion and increases epithelial cell invasion.
abstract: BACKGROUND
  The dynamic regulation of cell-cell adhesions is crucial for developmental processes, including tissue formation, differentiation and motility. Adherens junctions are important components of the junctional complex between cells and are necessary for maintaining cell homeostasis and normal tissue architecture. E-cadherin is the prototype and best-characterized protein member of adherens junctions in mammalian epithelial cells. Regarded as a tumour suppressor, E-cadherin loss is associated with poor prognosis in carcinoma. The E3 ubiquitin-ligase Hakai was the first reported posttranslational regulator of the E-cadherin complex. Hakai specifically targetted E-cadherin for internalization and degradation and thereby lowered epithelial cell-cell contact. Hakai was also implicated in controlling proliferation, and promoted cancer-related gene expression by increasing the binding of RNA-binding protein PSF to RNAs encoding oncogenic proteins. We sought to investigate the possible implication of Hakai in cell-substratum adhesions and invasion in epithelial cells.
  
  
  METHODS
  Parental MDCK cells and MDCK cells stably overexpressing Hakai were used to analyse cell-substratum adhesion and invasion capabilities. Western blot and immunofluoresecence analyses were performed to assess the roles of Paxillin, FAK and Vinculin in cell-substratum adhesion. The role of the proteasome in controlling cell-substratum adhesion was studied using two proteasome inhibitors, lactacystin and MG132. To study the molecular mechanisms controlling Paxillin expression, MDCK cells expressing E-cadherin shRNA in a tetracycline-inducible manner was employed.
  
  
  RESULTS
  Here, we present evidence that implicate Hakai in reducing cell-substratum adhesion and increasing epithelial cell invasion, two hallmark features of cancer progression and metastasis. Paxillin, an important protein component of the cell-matrix adhesion, was completely absent from focal adhesions and focal contacts in Hakai-overexpressing MDCK cells. The expression of Paxillin was found to be regulated by a proteasome-independent mechanism, possibly due to the decreased abundance of E-cadherin.
  
  
  CONCLUSIONS
  Taken together, these results suggest that Hakai may be involved in two hallmark aspects of tumour progression, the lowering cell-substratum adhesion and the enhancement of cell invasion.
authors: Translational Cancer Research Group, Instituto de Investigación Biomédica A Coruña (INIBIC), Complejo Hospitalario Universitario A Coruña (CHUAC), SERGAS, A Coruña, Spain.
authors: Teresa
authors: T
authors: Rodríguez-Rigueiro
authors: Manuel
authors: M
authors: Valladares-Ayerbes
authors: Mar
authors: M
authors: Haz-Conde
authors: Luis A
authors: LA
authors: Aparicio
authors: Angélica
authors: A
authors: Figueroa
mesh_terms: D022005:Adherens Junctions / Q000378:metabolism; D015153:Blotting, Western; D002448:Cell Adhesion / Q000502:physiology*; D045744:Cell Line, Tumor; D021982:Cell-Matrix Junctions / Q000187:drug effects / Q000502:physiology*; D004847:Epithelial Cells / Q000502:physiology*; D051417:Focal Adhesion Kinase 1 / Q000378:metabolism; D006801:Humans; D009361:Neoplasm Invasiveness; D051419:Paxillin / Q000378:metabolism; D044767:Ubiquitin-Protein Ligases / Q000502:physiology*; D016596:Vinculin / Q000378:metabolism
chemical_list: D051419:Paxillin; D016596:Vinculin; C471638:CBLL1 protein, human; D044767:Ubiquitin-Protein Ligases; D051417:Focal Adhesion Kinase 1; C496050:PTK2 protein, human